Ad is loading...
Ad is loading...
LGOFX vs TRQZX
LGOFX vs TRQZX Comparison
Open Charts LGOFX vs TRQZX
Lord Abbett Growth Opportunities F
Price$28.92
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Z
Price$114.15
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
LGOFX vs TRQZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
TRQZX has more cash in the bank: 31.3B vs. LGOFX (550M). TRQZX pays higher dividends than LGOFX: TRQZX (0.68) vs LGOFX (0.00). LGOFX was incepted earlier than TRQZX: LGOFX (17 years) vs TRQZX (5 years). LGOFX is a more actively managed with annual turnover of: 149.00 vs. TRQZX (21.70). LGOFX (0) and TRQZX (0) have matching initial minimum investment requirements. LGOFX annual gain was more profitable for investors over the last year : 47.63 vs. TRQZX (15.92).
| LGOFX | TRQZX | LGOFX / TRQZX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 17 years | 5 years | - |
| Gain YTD | 39.038 | 13.255 | 295% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 550M | 31.3B | 2% |
| Annual Yield % from dividends | 0.00 | 0.68 | - |
| Returns for 1 year | 47.63 | 15.92 | 299% |
| Returns for 3 years | -14.94 | -12.04 | 124% |
| Returns for 5 years | 12.22 | N/A | - |
| Returns for 10 years | 19.41 | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LOGSX | 21.86 | 0.22 | +1.02% |
| Live Oak Health Sciences | |||
| CEVYX | 12.53 | 0.10 | +0.80% |
| Columbia Global Value Inst3 | |||
| MLGRX | 9.88 | 0.04 | +0.41% |
| NYLI Winslow Large Cap Growth Class R3 | |||
| ESISX | 14.52 | -0.01 | -0.07% |
| Parametric International Equity R6 | |||
| PIEIX | 26.09 | -0.10 | -0.38% |
| Principal Glb Emerging Markets Inst | |||